MRTX Insider Trading Activity and SEC Form 4 Filings
MRTX insider trading summary
No open-market insider purchases or sales of Mirati Therapeutics, Inc. (MRTX) have been reported on SEC Form 4 in the past 12 months.
Latest MRTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 16, 2024 | Benjamin Hickey | EVP, Chief Commercial Officer | Sell | $37K (631 @ $59.02) |
| Jan 16, 2024 | Jamie Christensen | EVP & Chief Scientific Officer | Sell | $57K (966 @ $59.02) |
| Jan 16, 2024 | Jamie Christensen | EVP & Chief Scientific Officer | Sell | $37K (631 @ $59.02) |
| Jan 16, 2024 | Benjamin Hickey | EVP, Chief Commercial Officer | Sell | $57K (966 @ $59.02) |
| Jan 8, 2024 | Benjamin Hickey | EVP, Chief Commercial Officer | Sell | $123K (2,090 @ $58.92) |
| Jan 4, 2024 | Jamie Christensen | EVP & Chief Scientific Officer | Sell | $90K (1,531 @ $58.81) |
| Dec 18, 2023 | Jamie Christensen | EVP & Chief Scientific Officer | Sell | $137K (2,387 @ $57.50) |
| Dec 13, 2023 | Benjamin Hickey | EVP, Chief Commercial Officer | Sell | $126K (2,220 @ $56.67) |
| Sep 8, 2023 | Jamie Christensen | EVP & Chief Scientific Officer | Sell | $85K (2,388 @ $35.63) |
| Aug 11, 2023 | Boxer Capital, LLC | Insider | Buy | $1.6M (57,533 @ $27.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.